Clinical Trial Update: Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing anagliptin with sitagliptin on LDL cholesterol in diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease
• Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• anagliptin (anagliptin)

Snippet

Sponsor: Institute for Clinical Effectiveness, Japan | Conditions: Dipeptidyl-Peptidase 4 Inhibitors, LDL Cholesterol | Phase 4 | Status: COMPLETED